This is the authors' abstract. We don't add key points for this paper.
Cancer is a major public health burden in both developed and developing countries. Plant derived agents are being used for the treatment of cancer. Several anticancer agents including taxol, vinblastine, vincristine, the camptothecin derivatives, topotecan and irinotecan, and etoposide derived from epipodophyllotoxin are in clinical use all over the world. A number of promising agents such as flavopiridol, roscovitine, combretastatin A-4, betulinic acid and silvestrol are in clinical or preclinical development.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mohammad Shoeb (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: